Posted in Probiotics

Physicians at City of Hope, working in collaboration with scientists at Translational Genomics Research Institute (TGen), have found that greater gut microbial diversity in patients with metastatic kidney cancer is associated with better treatment outcomes on Food and Drug Administration-approved immunotherapy regimens. Their findings are outlined in a study published in the journal European Urology.
“We also reported the changes over time in the gut microbiome that occur during the c...

A recent study in France demonstrated that a 30-day treatment with the probiotic Bifidobacterium longum 35624 resulted in a significant improvement in symptoms of irritable bowel for approximately two-thirds of patients with IBS. Irritable bowel syndrome (IBS) is a chronic gut-brain disorder that can cause a variety of uncomfortable gastrointestinal symptoms including abdominal pain and diarrhoea, constipation, or a mix of the two. IBS can reduce quality of life, often results in m...

The gut microbiota-brain axis plays an important role in gastrointestinal function and regulating mood, anxiety, and pain, by communicating with the brain. Most studies have used animal models, however the following is a human double-blind study. This study provides multidimensional evidence that administration of a multi-strain probiotic (the probiotic studied is available in the United States as Omni-Biotic Stress Release) and the associated change in gut microbiota composition has a signi...

A recent randomized, controlled trial of 80 patients receiving H. pylori quadruple eradication therapy with bismuth demonstrated that adding L. reuteri for 1 month improved gastrointestinal symptom reduction to 42 percent of patients, compared with just 19 percent without the probiotic. Among 80 patients receiving bismuth-containing quadruple eradication therapy, abdominal pain symptoms decreased in 42% of those given the probiotic (Lactobacillus reuteri) versus 19% with placebo (OR 0.27,...